I am confused. It seems like this report does not acknowledge that the FDA should by most reasonable perspectives be considered a pretty major failure responsible for enormous harms to economic productivity and innovation.
Like, I think it’s reasonable to disagree with that take and to think the FDA is good, but somehow completely ignoring the question of FDA efficacy seems kinda crazy.
The report is focussed on preventing harms of technology to people using or affected by that tech.
It uses FDA’s mandate of premarket approval and other processes as examples of what could be used for AI.
Restrictions to economic productivity and innovation is a fair point of discussion. I have my own views on this – generally I think the negative assymetry around new scalable products being able to do massive harm gets neglected by the market. I’m glad the FDA exists to counteract that.
The FDA’s slow response to ramping up COVID vaccines during the pandemic is questionable though, as one example. Getting a sense there is a lot of problems with bureacracy and also industrial capture with FDA.
I am confused. It seems like this report does not acknowledge that the FDA should by most reasonable perspectives be considered a pretty major failure responsible for enormous harms to economic productivity and innovation.
Like, I think it’s reasonable to disagree with that take and to think the FDA is good, but somehow completely ignoring the question of FDA efficacy seems kinda crazy.
The report is focussed on preventing harms of technology to people using or affected by that tech.
It uses FDA’s mandate of premarket approval and other processes as examples of what could be used for AI.
Restrictions to economic productivity and innovation is a fair point of discussion. I have my own views on this – generally I think the negative assymetry around new scalable products being able to do massive harm gets neglected by the market. I’m glad the FDA exists to counteract that.
The FDA’s slow response to ramping up COVID vaccines during the pandemic is questionable though, as one example. Getting a sense there is a lot of problems with bureacracy and also industrial capture with FDA.
The report does not focus on that though.